AzTrials
AzTrials

Gastric UltrasoundNCT03205774

Positioning and Ultrasound Examination of the Gastric Antrum

A study testing 6 hours fasting and free oral intake of water in people with Gastric Ultrasound, run by Hôpital Edouard Herriot at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this prospective study was to assess the effect of patient positioning on the ultrasound assessment of gastric contents. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Gastric Ultrasound
What is being tested?
6 hours fasting and free oral intake of water
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
25 participants
Where
1 siteFrance
Study dates
3 Jul 2017to 20 Jan 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • ASA 1 and 2 volunteers

Who cannot join

  • Diabetes mellitus
  • previous gastrointestinal surgery
  • Medication affecting gastric motility
  • digestive diseases, gastroparesis
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital Femme Mère Enfant

    Lyon, 69500

Other trials in France

About this study

Official title: Effect of Positioning on Ultrasound Examination of the Gastric Antrum

The aim of this prospective study was to assess the effect of patient positioning on the ultrasound assessment of gastric contents.

Being tested
6 hours fasting and free oral intake of water

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 6 hours fasting and free oral intake of waterBehavioural

    Ultrasound examination of the gastric antrum are performed in volunteers after prolonged fasting and 10 min after oral intake of water. Volunteer should be lying on his/her back, right lateral decubitus position and left lateral decubitus position with randomization of the order.

Study groups in NCT03205774
Study groupRoleWhat they receive
Supine positionSham comparatorpatient in supine position, lying on the back, turned in the right lateral decubitus and turned in the left lateral decubitus in a randomized way, after prolonged fasting and 10 min after free oral intake of water
Receives: Behavioral: 6 hours fasting and free oral intake of water
30° semirecumbent positionSham comparatorpatient in semirecumbent position (head of the bed elevated to 30°), lying on the back, turned in the right lateral decubitus and turned in the left lateral decubitus in a randomized way, after prolonged fasting and 10 min after free oral intake of water
Receives: Behavioral: 6 hours fasting and free oral intake of water
45° semirecumbent positionSham comparatorpatient in semirecumbent position (head of the bed elevated to 45°), lying on the back, turned in the right lateral decubitus and turned in the left lateral decubitus in a randomized way, after prolonged fasting and 10 min after free oral intake of water
Receives: Behavioral: 6 hours fasting and free oral intake of water
90° semirecumbent positionSham comparatorpatient in semirecumbent position (head of the bed elevated to 90°), lying on the back, after prolonged fasting and 10 min after free oral intake of water
Receives: Behavioral: 6 hours fasting and free oral intake of water

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in ultrasound measurement of the antral cross sectional area according to the position

    Ultrasound measurement of antral cross-sectional area

    Measured: through study completion, an average of 20 min

  2. Change in qualitative ultrasound assessment of gastric contents according to the position

    qualitative ultrasound assessment of gastric contents

    Measured: through study completion, an average of 20 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jul 2017
  2. Study start3 Jul 2017
  3. Primary completion20 Jan 2018
  4. Study completion20 Jan 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03205774
Sponsor's protocol ID
L16-190
Status last verified
May 2018
First submitted
28 Jun 2017
Last updated
7 May 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing 6 hours fasting and free oral intake of water in people with Gastric Ultrasound, run by Hôpital Edouard Herriot at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in ultrasound measurement of the antral cross sectional area according to the position (time frame: through study completion, an average of 20 min). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in